Floatz logo

Misoprostol

Dystocia

University of Texas at AustinSmall moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Dystocia cohort.

Asset / SponsorPhaseRating
Oxytocin
Assiut University
Phase 4BB

Same molecule, other indications

Misoprostol is also rated in:

obstetric disorderActive
BBB
Indicative · Phase 4
73 / 100
View asset →
obesity disorderActive
B
Indicative · Phase 4
61 / 100
View asset →
metabolic dysfunction-associated steatohepatitisActive
B
Indicative · Phase 2
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →